Cases 1 - 10 of 10
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Crystal Pharmaceutical (Suzhou) Co., Ltd. v. Eisai, Inc.
as 23-1017
Appellant:
CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. and BERGEN PHARMACEUTICAL, LLC
Appellee:
EISAI, INC.
Neurocrine Biosciences, Inc. v. Sandoz Inc. et al
as 1:2022cv01124
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Sandoz Inc., Sandoz AG, Sandoz International GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd.
as 1:2021cv01797
Counter Defendant:
Novartis Pharmaceuticals Corporation
Counter Claimant:
Crystal Pharmaceutical (Suzhou) Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al
as 1:2021cv01464
Counter Defendant:
Neurocrine Biosciences, Inc.
Counter Claimant:
Crystal Pharmaceutical (Suzhou) Co., Ltd.
Defendant:
Crystal Pharmatech Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd.
as 1:2021cv01452
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Crystal Pharmaceutical (Suzhou) Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd.
as 1:2021cv01347
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Crystal Pharmaceutical (Suzhou) Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al
as 1:2021cv01067
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
